Zoetis

Q2 FY2026 EarningsQ2 FY26 results slightly missed consensus on the top line ($2.47B vs. $2.51B) but marginally beat on adjusted earnings ($1.87 vs. $1.85). The U.S. Companion Animal segment faced severe pressure, declining 11% YoY due to price sensitivity and generic competition, which overshadowed a strong 23% growth in U.S. Livestock. Most critically, management drastically cut FY26 full-year guidance, slashing organic revenue growth targets from 2-5% down to (3)-(1)%, citing persistent macro headwinds and intensified competition.